Novavax offers first evidence that COVID vaccines protect people against variants.

Callaway, Ewen; Mallapaty, Smriti

Callaway, Ewen; Mallapaty, Smriti.

Nature ; 590(7844): 17, 2021 02.

Article in English | MEDLINE | ID: covidwho-1080925

Subject(s)

Biotechnology; COVID-19 Vaccines/immunology; COVID-19/prevention & control; COVID-19/virology; Genetic Variation/genetics; SARS-CoV-2/genetics; SARS-CoV-2/immunology; COVID-19 Vaccines/adverse effects; COVID-19 Vaccines/chemistry; COVID-19 Vaccines/genetics; Clinical Trials as Topic; Drug Industry; Humans; Immunization, Secondary/methods; SARS-CoV-2/chemistry; SARS-CoV-2/classification; South Africa/epidemiology; Spike Glycoprotein, Coronavirus/chemistry; Spike Glycoprotein, Coronavirus/genetics; Spike Glycoprotein, Coronavirus/immunology; United Kingdom/epidemiology

Keywords

SARS-CoV-2; Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Genetic Variation / Biotechnology / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Africa / Europa Language: English Journal: Nature Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google